Literature DB >> 19551365

High-throughput screening of the cyclic AMP-dependent protein kinase (PKA) using the caliper microfluidic platform.

Leonard J Blackwell1, Steve Birkos, Rhonda Hallam, Gretchen Van De Carr, Jamie Arroway, Carla M Suto, William P Janzen.   

Abstract

Inhibitors of kinase activities can be mechanistically diverse, genomically selective, and pathway sensitive. This potential has made these biological targets the focus of a number of drug discovery and development programs in the pharmaceutical industry. To this end, the high-throughput screening of kinase targets against diverse chemical libraries or focused compound collections is at the forefront of the drug discovery process. Thus, the platform technology used to screen such libraries must be flexible and produce reliable and comparable data. The Caliper HTS microfluidic platform provides a direct determination of a peptidic substrate and phosphorylated product through the electrophoretic separation of the two species. The resulting data are reliable and comparable among screens and cover a broad range of biological targets, provided there is a definable peptide substrate that permits separation. Here we present a method for the high-throughput screening of the cyclic AMP-dependent protein kinase (PKA) as an example of the simplicity of this microfluidic platform.

Mesh:

Substances:

Year:  2009        PMID: 19551365     DOI: 10.1007/978-1-60327-258-2_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

2.  Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype.

Authors:  Calla M Olson; Yanke Liang; Alan Leggett; Woojun D Park; Lianbo Li; Caitlin E Mills; Selma Z Elsarrag; Scott B Ficarro; Tinghu Zhang; Robert Düster; Matthias Geyer; Taebo Sim; Jarrod A Marto; Peter K Sorger; Ken D Westover; Charles Y Lin; Nicholas Kwiatkowski; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-03-21       Impact factor: 8.116

3.  Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18.

Authors:  Catherine Simpson; Nathaniel G Jones; Emily A Hull-Ryde; Dmitri Kireev; Michael Stashko; Keliang Tang; Jim Janetka; Scott A Wildman; William J Zuercher; Matthieu Schapira; Raymond Hui; William Janzen; L David Sibley
Journal:  ACS Infect Dis       Date:  2015-12-28       Impact factor: 5.084

Review 4.  Advances in mass spectrometry-based post-column bioaffinity profiling of mixtures.

Authors:  Jeroen Kool; Martin Giera; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-24       Impact factor: 4.142

5.  A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination.

Authors:  Amalie Frederikke Rudolf; Tine Skovgaard; Stefan Knapp; Lars Juhl Jensen; Jens Berthelsen
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

6.  New tools for carbohydrate sulfation analysis: heparan sulfate 2-O-sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors.

Authors:  Dominic P Byrne; Yong Li; Krithika Ramakrishnan; Igor L Barsukov; Edwin A Yates; Claire E Eyers; Dulcé Papy-Garcia; Sandrine Chantepie; Vijayakanth Pagadala; Jian Liu; Carrow Wells; David H Drewry; William J Zuercher; Neil G Berry; David G Fernig; Patrick A Eyers
Journal:  Biochem J       Date:  2018-08-14       Impact factor: 3.857

7.  New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors.

Authors:  Dominic P Byrne; Yong Li; Pawin Ngamlert; Krithika Ramakrishnan; Claire E Eyers; Carrow Wells; David H Drewry; William J Zuercher; Neil G Berry; David G Fernig; Patrick A Eyers
Journal:  Biochem J       Date:  2018-08-14       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.